BioBuzz

There’s a bottleneck in biopharma most teams don’t see—until it delays everything.

It’s not manufacturing.
It’s not clinical.

It’s testing.

As therapies become more complex—especially in cell and gene therapy—outsourced testing has quietly become one of the biggest constraints on timelines, cost, and scalability.

Our latest piece breaks down the hidden friction:

➡️ Why outsourced testing isn’t scaling with innovation
➡️ How fragmented workflows and long turnaround times stall progress
➡️ What this signals for the future of CDMOs and development strategy

And importantly, where partners like Minaris are stepping in.

With integrated testing, analytical capabilities, and end-to-end support, Minaris is helping shift testing from a bottleneck to a strategic advantage—streamlining workflows, reducing risk, and accelerating timelines across development and commercialization.

But this is bigger than any one company.

👉 This is a system-level signal: infrastructure is racing to catch up with scientific innovation.

📖 Read the full article:
https://news.biobuzz.io/2026/03/31/how-complexity-in-outsourced-testing-creates-a-hidden-bottleneck-in-biopharma-development/

📣 Join the conversation in person

We’re bringing this discussion to the stage at our upcoming BioBuzz event with Minaris—where industry leaders will unpack how testing strategy is evolving and what it means for developers navigating today’s complexity.

👉 RSVP now: https://luma.com/jplvqg9t

Behind Every Therapy: Exploring the Role of Analytics and Biosafety in Bringing Medicines to Market · Luma This event is part of BioBuzz’s Insights to Impact Series, a curated program designed exclusively for life sciences industry leaders and ecosystem builders.…

🔥 Behind every breakthrough are the people who make it happen.

We're bringing those people together — scientists, founders, ecosystem builders, and YOU — for not 1 but 2 Oktoberfest-inspired gatherings this fall.

The first, in , in partnership with BioBeers + I-270 Innovation Labs:

📅 Oct 9 | 4-7pm
📍 Frederick, MD | FREE
🔗 RSVP: https://luma.com/86ntqd7u

The second, in , in partnership with CRB + ISPE:

📅 Oct 16 | 4:30-7:30pm
📍 Montgomery County, MD | FREE
🔗 RSVP: https://luma.com/wav9yi44

As Eva Szarek so eloquently shared earlier this week.... 🤖 AI isn't just the future of biopharma—it's happening NOW!

Life science leaders, entrepreneurs, investors, and regional stakeholders are invited to join us next Thursday, May 1 @ I-270 Innovation Labs in Frederick, MD, for our next 𝘐𝘮𝘱𝘢𝘤𝘵 𝘵𝘰 𝘐𝘯𝘴𝘪𝘨𝘩𝘵𝘴 event: 𝗟𝗲𝘃𝗲𝗿𝗮𝗴𝗶𝗻𝗴 𝗔𝗜 𝗔𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗕𝗶𝗼𝗣𝗵𝗮𝗿𝗺𝗮 𝗩𝗮𝗹𝘂𝗲 𝗖𝗵𝗮𝗶𝗻. 🤖

In addition to presentations from
- Kyle Nilson, PhD, Field Software Trainer, QIAGEN Digital Insights on their new PGXI pharmacogenomics knowledgebase and
- Carter Mitchell PhD, Chief Science Officer, Kemp Proteins, on how they're leveraging , , and high-throughput ( ) bio-manufacturing to accelerate protein-based and

Eva and Tammy Hanna, PhD, Director of Product, will be sharing more on AllSci.

🌐 AllSci offers an AI-powered research platform that allows pharma and biotech teams to accelerate innovation by rapidly validating or refuting scientific hypotheses, benchmarking competitors, and translating complex scientific data into actionable insights. Their proprietary AI-powered research intelligence (or AERIS AI) leverages advanced language models to break down scientific publications into hypotheses, research questions, and results—delivering unmatched clarity and accessibility.

AllSci's '𝗘𝘅𝗽𝗹𝗼𝗿𝗲' feature visualizes over 11 million hypotheses from biological literature, enabling you to 𝘂𝗻𝗰𝗼𝘃𝗲𝗿 𝗼𝘃𝗲𝗿𝗹𝗮𝗽𝗽𝗶𝗻𝗴 𝗰𝗼𝗻𝗰𝗲𝗽𝘁𝘀 𝗮𝗻𝗱 𝗵𝗶𝗱𝗱𝗲𝗻 𝗶𝗻𝘀𝗶𝗴𝗵𝘁𝘀. Explore science differently, watch how: https://www.youtube.com/watch?v=YaKcffLJFQ0

____________________________________________________

Hi, we're BioBuzz. 👋

Our mission is to build the most connected network of life science communities in the world to accelerate innovation.

Our Insights to Impact Event Series is by invitation-only and specifically for life science leaders, entrepreneurs, investors, and regional stakeholders committed to innovation, commercialization, and the growth of the region.

Is that you? Interested in joining us for this exclusive event? 🧬 𝗠𝗲𝘀𝘀𝗮𝗴𝗲 𝘂𝘀 𝗼𝗿 𝗲𝗺𝗮𝗶𝗹 𝗵𝗲𝗹𝗹𝗼[𝗮]𝗯𝗶𝗼𝗯𝘂𝘇𝘇.𝗶𝗼 𝗳𝗼𝗿 𝗺𝗼𝗿𝗲 𝗱𝗲𝘁𝗮𝗶𝗹𝘀.

____________________________________________________

A 𝗛𝗨𝗚𝗘 thank you to our Impact to Insights 𝗦𝗲𝗿𝗶𝗲𝘀 𝗦𝗽𝗼𝗻𝘀𝗼𝗿𝘀 for making this event possible. 👀 cc Ascend Advanced Therapies - ABL, CRB, Fulton Bank, Heffron Company, The Henry M. Jackson Foundation for the Advancement of Military Medicine, InfoPathways Inc., Project Farma (PF), QIAGEN, TEDCO, and Workforce Genetics.

We are thrilled to have Louis Licamele, PhD, Chief Development Officer, EVP of Clinical and Data Science, Bloom Science, Inc., join us next Thursday, May 1 @ I-270 Innovation Labs in Frederick, MD, as we discuss 𝗟𝗲𝘃𝗲𝗿𝗮𝗴𝗶𝗻𝗴 𝗔𝗜 𝗔𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗕𝗶𝗼𝗣𝗵𝗮𝗿𝗺𝗮 𝗩𝗮𝗹𝘂𝗲 𝗖𝗵𝗮𝗶𝗻. 🤖

Dr. Licamele is a dynamic leader at the intersection of science and technology, passionate about translating cutting-edge innovation into new therapies for patients with unmet medical needs. With over two decades of experience in the biotech and pharmaceutical industry, he has led efforts from early-stage discovery through pivotal Phase 3 trials and successful NDA submissions. A data-driven executive, Dr. Licamele is known for uncovering powerful insights and turning them into tangible value.

Dr. Licamele currently serves as Chief Development Officer and Executive Vice President of Clinical and Data Science at Bloom Science, where he oversees both clinical and product development. Previously, as Vice President of Biometrics at Regenxbio, he led Biostatistics and Clinical Data Management and drove initiatives in Clinical Innovation. At Vanda Pharmaceuticals, where he was Vice President of Informatics, Dr. Licamele played a key role in applying data science to rare diseases, developing novel clinical endpoints that supported regulatory approval and contributing to the launch of the first direct-to-consumer commercial launch for a rare disease product. He began his career in the Pharmacogenetics Department at Novartis AG.

Dr. Licamele holds a Ph.D. in Artificial Intelligence / Computer Science from the University of Maryland, where his research focused on developing computational methods for drug discovery. He also earned an M.S. in Computer Science from Maryland, and a B.S. in both Biology and Computer Science from Georgetown University, where he was a Howard Hughes Fellow.
_________________________________________________________

Hi, we're BioBuzz. 👋

Our mission is to build the most connected network of life science communities in the world to accelerate innovation.

If you're a life science leader, entrepreneur, investor, or regional stakeholder committed to innovation, commercialization, and growth, we invite you to join us for this invite-only event. 🧬 𝗠𝗲𝘀𝘀𝗮𝗴𝗲 𝘂𝘀 𝗼𝗿 𝗲𝗺𝗮𝗶𝗹 𝗵𝗲𝗹𝗹𝗼[𝗮]𝗯𝗶𝗼𝗯𝘂𝘇𝘇.𝗶𝗼 𝗳𝗼𝗿 𝗺𝗼𝗿𝗲 𝗱𝗲𝘁𝗮𝗶𝗹𝘀.

📢 Calling all life science leaders, entrepreneurs, investors, and regional stakeholders committed to innovation, commercialization, and the growth of the BioHealth Capital Region. 🧬

Join us next Thursday, May 1 in Frederick, MD, for our invite-only event as we discuss 𝗟𝗲𝘃𝗲𝗿𝗮𝗴𝗶𝗻𝗴 𝗔𝗜 𝗔𝗰𝗿𝗼𝘀𝘀 𝘁𝗵𝗲 𝗕𝗶𝗼𝗣𝗵𝗮𝗿𝗺𝗮 𝗩𝗮𝗹𝘂𝗲 𝗖𝗵𝗮𝗶𝗻. 🤖

In addition to presentations from Kemp Proteins, AllSci, and QIAGEN, our powerhouse panel, moderated by Chris Frew, will discuss how AI is transforming every stage of the biopharma lifecycle—accelerating progress and unlocking new possibilities for researchers, companies, and, most importantly, patients.

Hear from:
🐝 Eleanor Howe, CEO, Diamond Age Data Science
🐝 Louis Licamele, Chief Development Officer, EVP of Clinical + Data Science, Bloom Science
🐝 Thom Bethune, Vice President, InfoPathways
🐝 Usama Malik, Investor, President of COEUS + Founder of Regulatory AI startup (stealth)

𝗠𝗲𝘀𝘀𝗮𝗴𝗲 𝘂𝘀 𝗼𝗿 𝗲𝗺𝗮𝗶𝗹 𝗵𝗲𝗹𝗹𝗼[𝗮]𝗯𝗶𝗼𝗯𝘂𝘇𝘇.𝗶𝗼 𝗳𝗼𝗿 𝗺𝗼𝗿𝗲 𝗱𝗲𝘁𝗮𝗶𝗹𝘀.

A 𝗛𝗨𝗚𝗘 thank you to our Impact to Insights 𝗦𝗲𝗿𝗶𝗲𝘀 𝗦𝗽𝗼𝗻𝘀𝗼𝗿𝘀 for making this possible. 👀 We're looking at you Ascend-ABL, CRB, Fulton Bank, Heffron, The Henry M. Jackson Foundation for the Advancement of Military Medicine, InfoPathways Inc., Project Farma, QIAGEN, Maryland Technology Development Corporation - TEDCO, and Workforce Genetics.

And, of course, thank you to our partners like Funktional Brewing Company (cc Jon Rowley, Timothy Olsen, Ph.D., and Josh Ewin) and Wild Bay (cc Sid Sharma) for brewing up some fun.

🚨 𝗜𝗠𝗣𝗢𝗥𝗧𝗔𝗡𝗧 𝗜𝗡𝗙𝗢𝗥𝗠𝗔𝗧𝗜𝗢𝗡 🚨

This invite-only event is FREE for industry leaders and professionals, providing a unique opportunity to gain insights on important industry trends and connect with fellow life science professionals, entrepreneurs, and advocates in a peer-oriented setting. Vendor and service provider attendance is restricted and paid to ensure a high-value program.

A BioBuzz Christmas Tale 🧬 ❄️

’Twas the night before Christmas, and all through the hubs,
The labs were alive, from startups to pubs.
The community was bustling with care and with flair,
In hopes that BioBuzz soon would be there.

The Mid-Atlantic region was bustling with might,
From Frederick’s biomanufacturing light,
To Baltimore and Philadelphia labs,
All awaiting the spark that BioBuzz grabs.

The community all dreamed, their networks in tow,
Ready for matches that only BioBuzz could show.
While employers sighed, “Where’s talent to find?”
BioBuzz had the answer: a marketplace refined.

When out on the net there arose such a clatter,
I logged into BioBuzz to see what was the matter.
Away to my dashboard I clicked with delight,
And there it was glowing, a beautiful sight.

Regional connections, alive and well,
With all the jobs, events and insights that our stories could tell.
From North Carolina to Philly, the ecosystem was clear,
BioBuzz was building the future right here.

With a focus on community, its power was shown,
And a mission to make every talent pool known.
More rapid than research, the matches they came,
And BioBuzz shouted and called them by name:

“On Biotech! On Medtech! On Research and Testing!
On Hubs and on Labs, with job seekers investing!
To the top of the workforce, to industry heights,
We’ll power innovation with all of our might!”

As the community gathered, inspired to grow,
Connections ignited a regional glow.
So up through the networks, the partnerships flew,
With a hub full of talent and innovation too.

And then in a flash, I saw with surprise,
The joy of community before my own eyes.
The meetups, the mentoring, the stories of cheer,
Proved BioBuzz was more than just a career.

Its marketplace buzzed, its mission was clear,
To build a workforce for now and for years.
With AI and insights, the matches were merry,
And hiring once hard was now light to carry.

From Maryland’s corridors to Philly’s strong scene,
To the bustling labs where innovation gleams,
BioBuzz is there, connecting each strand,
Building the workforce with a steady hand.

It spoke not a word, but its platform did say,
“Grow your career, or your company, and do it your way.”
And laying its framework for all to behold,
It showed us the future, both vibrant and bold.

It sprang from the screen, to its team gave a cheer,
Empowering the region, year after year.
And I heard it exclaim, as it soared out of sight,
“Happy BioBuzz to all, and to all a good night!”

Happy Holidays to the most amazing community and people that we have the pleasure of working for! 🐝 ☃️

What's buzzin? Join me for a fun discussion about the future of hiring and ecosystem building in life sciences!

Episode 104: Buzzin' with Chris Frew Listen in as Desmond and Alec dive in with Chris Frew to discuss everything from Biobuzz to the community that it serves!

Join us for a free program with Ali Divan - a scientist by training with a deep passion for improving the lives of fellow scientists.

Career Catalyst: Showcasing Yourself to Success in Life Sciences Join us for our first ever Career Catalyst Community Office Hours Event!